“The Anatomy of an Epidemic: Stimulants, Psychotropic Drugs, and the Unbelievable Boom of Mental Disorders in the USA” (original: Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America ) - Robert Whitaker's book , published in 2010 by the Crown Publishing Group [1] [2] [3] . In the book, the author explores the reasons why the number of Americans diagnosed with a mental disorder almost doubled between 1987 and 2003 [4] . The author tries to answer the question why this happened, and in addition, explores the long-term prospects for people diagnosed with mental illness in the United States . In April 2011, the Association of Journalistic and Publishing Investigations (Investigative Reporters and Editors, IRE) awarded the book its prize for the best journalistic investigation of 2010, stating that “this book is an in-depth analysis of medical and scientific publications, rich in convincing concise examples. Ultimately, Whitaker criticizes the generally accepted notions of the treatment of mental disorders with medical methods ” [5] .
Content
Summary
Whitaker begins his study with a reminder that the effects of antipsychotics , benzodiazepines and antidepressants were discovered as side effects during studies of antihistamines ( promethazine ), gram-negative antibiotics (mefenesin) and anti-TB drugs . At that time, the psychotropic mechanisms of action of these drugs were not known, and they were first called strong tranquilizers (now this group of drugs is called antipsychotics) because of their ability to cause “euphoric calm”, weak tranquilizers (now benzodiazepines) and stimulants (now antidepressants ) due to the ability to cause in patients the effect of "dancing in the wards" [6] . These drugs were developed during the boom of the pharmaceutical industry , triggered by the adoption of the Durham-Humphrey Amendment of 1951 , which gave doctors a monopoly on prescribing drugs, thus effectively merging the interests of doctors and pharmaceutical companies. In addition, during this period, pharmacists invented the so-called “magic pills”, which were unusually effective for certain symptoms of diseases such as diabetes , which gave reason to advertise psychotropic drugs according to a similar scheme. Only many years later, the mechanisms of action of psychotropic drugs were discovered, and based on these findings, the serotonin hypothesis of depression and the dopamine hypothesis of schizophrenia were developed.
According to Whitaker’s primary literature analysis, reduced serotonin and increased dopamine levels were observed in patients only after taking antidepressants and antipsychotics, but not before [7] [8] [9] [10] [11] [12] [13] [ 14] [15] [16] [17] [18] [19] [20] [21] [22] [23] .
There is still no clear and convincing evidence that monoamine deficiency causes depression; that is, there is no such real mental problem as the "deficiency of monoamines."
Original textSo far there is no clear and convincing evidence that monoamine deficiency accounts for depression; that is, there is no "real" monoamine deficit.- Stephen Stahl Essential Psychopharmacology [24]
Whitaker also refutes the theory of “magic pills” in another way: he demonstrates the mythical nature of the widespread belief that the invention of chlorpromazine (chlorpromazine) made it possible to practically free psychiatric clinics from patients [25] . He begins by pointing out that in the late 1940s and 1950s, approximately 75% of those who had a first episode of schizophrenia completed treatment for no more than three years (chlorpromazine was released in 1955 ) [26] [27] [28] . It is further noted that the appearance of chlorpromazine did not improve recovery rates among patients who were first diagnosed with schizophrenia. In fact, according to Whitaker, the release of psychiatric clinics from patients was not facilitated by the emergence of antipsychotic drugs , but by the launch in 1965 of the state programs Medicare and Medicaid , which provided funding for nursing homes , but did not provide funding for psychiatric clinics, which naturally entailed a massive referral of patients from psychiatric clinics to nursing homes.
The author supports the idea of using psychotropic drugs for mental disorders, but advocates their cautious prescription, rejection of the opinion that they “correct the chemical imbalance in the body” and for their short-term use [29] .
According to Whitaker, the mass prescription of psychotropic drugs to patients acquires the features of an iatrogenic epidemic: the cause of impaired functioning of the patient’s brain is actually the medications prescribed to him [30] .
The author believes that the aura of glory of “miracle drugs”, which at first accompanied psychotropic medicines, has long disappeared. He considers the active advertising of popular atypical antipsychotics “one of the most outrageous pages in the history of psychiatry, since one scientific study after another shows that their effectiveness is not at all higher than the effectiveness of first-generation antipsychotics” [31] .
Whitaker gives an example of the method of Professor Jaakko Seikkula from the hospital in Tornio ( Finland ), which prescribes medicines to patients in limited quantities, which leads to positive results [32] . Whitaker also believes that patients with a diagnosis of depression should exercise. For example, in the UK, exercise was so effective in depression that a doctor can prescribe exercise as a treatment. Studies have shown significant effectiveness of exercise, even in the short term [33] [34] [35] .
Whitaker warns against prescribing medications to children. The author notes that a child can be prescribed a whole “cocktail” of drugs in order to adjust his behavior, but as a result of such a careless attitude, after a few years the child can be turned into a disabled person [36] .
Survey of research data and statistics
Whitaker spent one and a half years studying the materials for this book [30] . Some of the most important studies are available on the author’s website [37] .
See also
- Controversy surrounding biopsychiatry
- Conflict of Interest and Clinical Research in Psychiatry
- The myth of mental illness
- The whole truth about drugs: a global conspiracy of pharmaceutical companies
- Breggin, Peter Roger
Notes
- ↑ Fitzpatrick, Laura . The Skimmer , Time (May 3, 2010). Archived on September 23, 2010. Date of treatment October 5, 2010.
- ↑ Burch, Druin . Does psychiatry make us mad? , New Scientist , Reed Business Information (April 7, 2010). Archived October 25, 2010. Date of treatment October 5, 2010.
- ↑ Good, Alex . Book review: Anatomy of an Epidemic , The Record , Metroland Media (May 21, 2010). Archived October 26, 2010. Date of treatment October 5, 2010.
- ↑ Whitaker, p. 7
- ↑ IRE Awards 2010 (unreachable link) . Investigative Reporters and Editors. Date of treatment May 11, 2011. Archived on September 15, 2011.
- ↑ Whitaker, Robert. Anatomy of an Epidemic. - Crown Publishing Group, 2010. - P. 48–54. - ISBN 978-0-307-45241-2 .
- ↑ M. Bowers; Heninger, GR; Gerbode, F. Cerebrospinal fluid 5-hydroxyindoleactiic acid and homovanillic acid in psychiatric patients (Eng.) // International Journal of Neuropharmacology : journal. - 1969. - Vol. 8 , no. 3 . - P. 255-262 . - PMID 5796265 .
- ↑ R. Papeschi; McClure, DJ Homovanillic and 5-hydroxyindoleacetic acid in cerebrospinal fluid of depressed patients (Eng.) // Archives of General Psychiatry : journal. - 1971. - Vol. 25 , no. 4 . - P. 354-358 . - PMID 5116990 .
- ↑ M. Bowers. Lumbar CSF 5-hydroxyindoleacetic acid and homovanillic acid in affective syndromes (English) // Journal of Nervous and Mental Disease : journal. - Lippincott Williams & Wilkins 1974. - Vol. 158 , no. 5 . - P. 325-330 . - DOI : 10.1097 / 00005053-197405000-00003 . - PMID 4823933 .
- ↑ M. Asberg; Thorén, P; Träskman, L; Bertilsson, L; Ringberger, V. "Serotonin depression" - a biochemical subgroup within the affective disorders? (English) // Science: journal. - 1976. - Vol. 191 , no. 4226 . - P. 478-480 . - DOI : 10.1126 / science.1246632 . - PMID 1246632 .
- ↑ J. Maas; Koslow, SH; Katz, MM; Bowden, CL; Gibbons, RL; Stokes, PE; Robins, E; Davis, JM Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs (English) // American Journal of Psychiatry : journal. - 1984. - Vol. 141 , no. 10 . - P. 1159-1171 . - PMID 6207736 .
- ↑ J. Lacasse; Leo, Jonathan. Serotonin and depression: a disconnect between the advertisements and the scientific literature // PloS Medicine: journal. - 2005. - Vol. 2 , no. 12 . - P. 1211-1216 . - DOI : 10.1371 / journal.pmed.0020392 . - PMID 16268734 .
- ↑ M. Bowers. Central dopamine turnover in schizophrenic syndromes (eng.) // Archives of General Psychiatry : journal. - 1974. - Vol. 31 , no. 1 . - P. 50-54 . - PMID 4835986 .
- ↑ R. Post; Fink, E; Carpenter Jr, WT; Goodwin, FK Cerebrospinal fluid amine metabolites in acute schizophrenia (rum.) // Archives of General Psychiatry . - 1975.- T. 32 , nr. 8 . - P. 1063-1068 . - PMID 1156113 .
- ↑ J. Haracz. The dopamine hypothesis: an overview of studies with schizophrenic patients (English) // Schizophrenia Bulletin : journal. - 1982. - Vol. 8 , no. 3 . - P. 438-458 . - PMID 6127808 .
- ↑ T. Lee; Seeman, P; Tourtellotte, WW; Farley, IJ; Hornykeiwicz, O. Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains (English) // Nature: journal. - 1978. - Vol. 274 , no. 5674 . - P. 897-900 . - DOI : 10.1038 / 274897a0 . - . - PMID 683328 .
- ↑ D. Burt; Creese, I; Snyder, SH Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain (Eng.) // Science: journal. - 1977. - Vol. 196 , no. 4287 . - P. 326—327 . - DOI : 10.1126 / science.847477 . - PMID 847477 .
- ↑ M. Porceddu; Ongini, E; Biggio, G. [3H] SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors (Eng.) // European Journal of Pharmacology : journal. - 1985. - Vol. 118 , no. 3 . - P. 367-370 . - DOI : 10.1016 / 0014-2999 (85) 90 151-7 . - PMID 2935413 .
- ↑ A. MacKay; Iversen, LL; Rossor, M; Spokes, E; Bird, E; Arregui, A; Creese, I; Synder, SH Increased brain dopamine and dopamine receptors in schizophrenia (Eng.) // Archives of General Psychiatry : journal. - 1982. - Vol. 39 , no. 9 . - P. 991-997 . - PMID 7115016 .
- ↑ J. Kornhuber; Riederer, P; Reynolds, GP; Beckmann, H; Jellinger, K; Gabriel, E. 3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms (Eng.) // Journal of Neural Transmission : journal. - 1989. - Vol. 75 , no. 1 . - P. 1-10 . - DOI : 10.1007 / BF01250639 . - PMID 2563750 .
- ↑ J. Martinot; Peron-Magnan, P; Huret, JD; Mazoyer, B; Baron, JC; Boulenger, JP; Loc'h, C; Maziere, B; Caillard, V. Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br] bromospiperone in untreated schizophrenic patients (English) // American Journal of Psychiatry : journal. - 1990. - Vol. 147 , no. 1 . - P. 44-50 . - PMID 2293788 .
- ↑ L. Farde; Wiesel, FA; Stone-Elander, S; Halldin, C; Nordström, AL; Hall, H; Sedvall, G. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C] raclopride (Eng.) // Archives of General Psychiatry : journal. - 1990. - Vol. 47 , no. 3 . - P. 213-219 . - PMID 1968328 .
- ↑ J. Hietala; Syvälahti, E; Vuorio, K; Någren, K; Lehikoinen, P; Ruotsalainen, U; Räkköläinen, V; Lehtinen, V; Wegelius, U. Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography (Eng.) // Archives of General Psychiatry : journal. - 1994. - Vol. 51 , no. 2 . - P. 116-123 . - PMID 7905257 .
- ↑ Stahl, Stephen. Essential Psychopharmacology. - Cambridge University Press, 2000. - P. 187. - ISBN 0-521-64154-3 .
- ↑ Whitaker, Robert. Anatomy of an Epidemic: Psychiatric Drugs and the Astonishing Rise of Mental Illness in America // Ethical Human Psychology and Psychiatry: journal. - Springer. - Vol. 7 , no. I. - P. 1 .
- ↑ Warner, R. Recovery from Schizophrenia. - Boston: Routledge & Kegan Paul, 1985 .-- P. 74.
- ↑ N. Lehrman. Follow-up of brief and prolonged psychiatric hospitalization (English) // Comprehensive Psychiatry : journal. - 1961. - Vol. 2 . - P. 227-240 .
- ↑ Cole, J. Psychopharmacology. - Washington DC: National Academy of Sciences, 1959. - P. 142, 386–87.
- ↑ Lipinski, Jed . "Anatomy of an Epidemic": The hidden damage of psychiatric drugs , Salon , Salon Media (April 27, 2010). Archived on October 2, 2010. Date of treatment October 9, 2010.
- ↑ 1 2 Whitaker, p. 210
- ↑ Whitaker, p. 303
- ↑ Whitaker, p. 343
- ↑ F. Dimeo. Benefits from aerobic exercise in patients with major depression (English) // British Journal of Sports Medicine : journal. - 2001. - Vol. 35 , no. 2 . - P. 114-117 . - PMID 11273973 .
- ↑ K. Knubben. A randomized, controlled study on the effects of a short-term endurance training program in patients with major depression (Eng.) // British Journal of Sports Medicine : journal. - 2007. - Vol. 41 , no. 1 . - P. 29-33 . - DOI : 10.1136 / bjsm.2006.030130 . - PMID 17062659 .
- ↑ A. Strohle. Physical activity, exercise, depression and anxiety disorders (Eng.) // Journal of Neural Transmission : journal. - 2009. - Vol. 116 , no. 6 . - P. 29-33 . - DOI : 10.1007 / s00702-008-0092-x . - PMID 18726137 .
- ↑ Whitaker, chapters 11 and 12
- ↑ Whitaker, Robert. Mad in America . Date of treatment October 10, 2010. Archived December 12, 2012.
Literature
- Whitaker, Robert. Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America. - Crown (Random House), April 13, 2010 .-- ISBN 978-0-307-45241-2 .
Links
- Book home page at author's site, Mad in America
- Author keynote at Alternatives 2010 (funded by the Substance Abuse & Mental Health Services Administration of the US Department of Health and Human Services)